For: | Ye HH, Ye JZ, Xie ZB, Peng YC, Chen J, Ma L, Bai T, Chen JZ, Lu Z, Qin HG, Xiang BD, Li LQ. Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein. World J Gastroenterol 2016; 22(13): 3632-3643 [PMID: 27053855 DOI: 10.3748/wjg.v22.i13.3632] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i13/3632.htm |
Number | Citing Articles |
1 |
Toshiya Kamiyama, Tatsuhiko Kakisaka, Tatsuya Orimo, Kenji Wakayama. Hepatectomy for hepatocellular carcinoma with portal vein tumor thrombus. World Journal of Hepatology 2017; 9(36): 1296-1304 doi: 10.4254/wjh.v9.i36.1296
|
2 |
Is hepatocellular carcinoma complicated with portal vein tumor thrombosis potentially curable by radiotherapy in the form of stereotactic body radiation therapy?. International Journal of Radiation Biology 2022; 98(10): 1495 doi: 10.1080/09553002.2022.2055800
|
3 |
Francisco Tustumi, Fabricio Ferreira Coelho, Daniel de Paiva Magalhães, Sérgio Silveira Júnior, Vagner Birk Jeismann, Gilton Marques Fonseca, Jaime Arthur Pirola Kruger, Luiz Augusto Carneiro D'Albuquerque, Paulo Herman. Treatment of hepatocellular carcinoma with macroscopic vascular invasion: A systematic review and network meta-analysis. Transplantation Reviews 2023; 37(3): 100763 doi: 10.1016/j.trre.2023.100763
|
4 |
Zun-Yi Zhang, Ke-Shuai Dong, Er-Lei Zhang, Li-Wei Zhang, Xiao-Ping Chen, Han-Hua Dong. Resection might be a meaningful choice for hepatocellular carcinoma with portal vein thrombosis. Medicine 2019; 98(50): e18362 doi: 10.1097/MD.0000000000018362
|
5 |
Seikan Hai, Etsuro Hatano, Toshihiro Okada, Naoki Uyama, Kazuhiro Suzumura, Jiro Fujimoto. Is Noncurative Hepatic Resection Justified for Advanced Hepatocellular Carcinoma?. The American Surgeon™ 2018; 84(12): 1938 doi: 10.1177/000313481808401241
|
6 |
Aline Mähringer-Kunz, Verena Steinle, Roman Kloeckner, Sebastian Schotten, Felix Hahn, Irene Schmidtmann, Jan Bernd Hinrichs, Christoph Düber, Peter Robert Galle, Hauke Lang, Arndt Weinmann, Gregory Tiao. The impact of portal vein tumor thrombosis on survival in patients with hepatocellular carcinoma treated with different therapies: A cohort study. PLOS ONE 2021; 16(5): e0249426 doi: 10.1371/journal.pone.0249426
|
7 |
K.-S. Jeng, C.-C. Huang, C.-S. Chung, C.-K. Lin, C.-J. Teng, P.-W. Shueng, K.-H. Chen. Transplantation After Successful Downstaging by Multimodal Treatments of American Joint Committee on Cancer Stage IIIB Hepatocellular Carcinoma With Portal Vein Thrombi: A Case Report. Transplantation Proceedings 2018; 50(9): 2882 doi: 10.1016/j.transproceed.2017.11.081
|
8 |
Li Xu, Shanshan Chen, Haijun Cao, Zemin Feng, Chao Yang. Efficacy of sorafenib plus transcatheter arterial chemoembolization in treating hepatocellular carcinoma with portal vein tumor thrombosis: A meta-analysis. Acta Pharmaceutica 2024; 74(3): 405 doi: 10.2478/acph-2024-0019
|
9 |
Saikang Tang, Yingming Gao, Xue Yan, Weihua Zhi, Yue Han. Effectiveness and safety of vascular intervention plus lenvatinib versus vascular intervention alone for hepatocellular carcinoma patients with portal vein tumor thrombus: a retrospective comparative study. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1431069
|